Overview

Chitosan is a naturally derived biopolymer produced through the alkaline deacetylation of chitin, the second most abundant polysaccharide in nature after cellulose. Chitin is found primarily in the exoskeletons of crustaceans such as shrimp, crabs, and lobsters, as well as in the cell walls of certain fungi. The resulting chitosan polymer possesses unique physicochemical properties, including a positive charge at acidic pH, which enables it to interact with negatively charged molecules such as dietary fats and bile acids.

In the dietary supplement industry, chitosan is marketed primarily as a weight management aid based on its ability to bind dietary lipids in the gastrointestinal tract, theoretically reducing fat absorption. Some studies have also investigated its potential to lower LDL cholesterol levels through bile acid sequestration. However, clinical evidence for significant weight loss effects has been mixed, with several systematic reviews concluding that the magnitude of fat-binding in practical use is modest at best.

Beyond supplementation, chitosan has extensive applications in biomedical engineering, wound healing, drug delivery systems, and water purification due to its biocompatibility, biodegradability, and antimicrobial properties. Medical-grade chitosan dressings are used in hemostatic applications to control bleeding. As a supplement, it is generally well-tolerated, though individuals with shellfish allergies should be aware of its crustacean-derived origin, and it may interfere with the absorption of fat-soluble vitamins and certain medications.

Mechanism of Action

Cationic Polysaccharide — Fat Binding Mechanism

Chitosan is a linear copolymer of N-acetylglucosamine and glucosamine derived from alkaline deacetylation of chitin (the structural polysaccharide in crustacean exoskeletons, insect cuticles, and fungal cell walls). At gastric pH (< 6.5), chitosan's free amino groups (pKa ~ 6.3) become protonated, creating a polycationic polymer that electrostatically binds negatively charged dietary lipids — bile acids, free fatty acids, and phospholipids — forming insoluble chitosan-lipid complexes that resist pancreatic lipase digestion and are excreted fecally. This mechanism can reduce dietary fat absorption by approximately 15-25% depending on the degree of deacetylation and molecular weight (PMID: 18691268).

Bile Acid Sequestration & Cholesterol Lowering

Chitosan binds bile acids (primarily taurocholic and glycocholic acid) in the intestinal lumen through ionic interactions between protonated amino groups and bile acid carboxylate/sulfonate groups. This interrupts enterohepatic bile acid recirculation, forcing hepatic conversion of cholesterol to new bile acids via CYP7A1 (cholesterol 7-alpha-hydroxylase), thereby reducing circulating LDL cholesterol by 5-15%. Chitosan also reduces intestinal cholesterol absorption by competing with micellar solubilization (PMID: 18203864).

Mucoadhesive & Antimicrobial Properties

Chitosan exhibits strong mucoadhesive properties due to electrostatic interactions between its cationic amino groups and anionic sialic acid residues and sulfate groups on mucin glycoproteins. This mucoadhesion enables chitosan to reversibly open tight junctions between epithelial cells by redistributing ZO-1 and occludin proteins through activation of protein kinase C (PKC), enhancing paracellular drug absorption. Its antimicrobial activity results from electrostatic disruption of negatively charged bacterial cell membranes, causing leakage of intracellular contents (PMID: 16978003).

Hemostatic & Wound Healing Activity

Chitosan activates platelet adhesion and aggregation through electrostatic interaction with platelet membrane phospholipids and glycoprotein receptors. It also enhances macrophage phagocytic activity and stimulates fibroblast proliferation, accelerating wound closure and collagen deposition (PMID: 19540252).

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Gastrointestinal symptoms are most prevalent: bloating, gas, nausea, diarrhea, and constipation
• Abdominal cramping and stomach discomfort
• Fishy body odor in some individuals (due to trimethylamine production from chitosan metabolism in some formulations)
• Malabsorption of fat-soluble vitamins (A, D, E, K) with chronic use, as chitosan binds dietary fats in the GI tract
• Mild allergic reactions including skin rash and itching

Serious Adverse Effects

• Anaphylaxis in individuals with shellfish or crustacean allergy, as most commercial chitosan is derived from shrimp and crab shells
• Fat-soluble vitamin deficiency (vitamins A, D, E, K) with prolonged use, potentially leading to coagulopathy (vitamin K), bone loss (vitamin D), or immune dysfunction
• Essential fatty acid deficiency with chronic high-dose use due to fat-binding properties
• Potential for medication malabsorption affecting therapeutic drug levels
• Intestinal obstruction has been reported in rare cases with high doses and inadequate fluid intake

Contraindications

• Known allergy to shellfish, crustaceans, or chitin (the precursor to chitosan)
• Pregnancy and breastfeeding: insufficient safety data and risk of fat-soluble nutrient malabsorption affecting fetal development
• Malabsorption syndromes or conditions requiring careful fat-soluble vitamin management
• Patients on narrow therapeutic index medications where absorption variability could be dangerous
• Active gastrointestinal obstruction or severe motility disorders

Drug Interactions

• Fat-soluble medications: chitosan may reduce absorption of fat-soluble drugs including oral contraceptives, warfarin, fat-soluble vitamins, and certain antiretrovirals
• Warfarin and anticoagulants: dual risk of reduced absorption AND vitamin K depletion, making anticoagulation unpredictable; close INR monitoring is essential
• Oral contraceptives: potential reduced efficacy due to fat-binding interference; consider alternative contraceptive methods
• Statin medications: theoretical reduction in absorption, though clinical significance is uncertain
• Mineral supplements (calcium, magnesium, zinc): chitosan may bind and reduce absorption

Special Populations

• Obese individuals seeking weight loss: clinical evidence for chitosan as a weight-loss supplement is modest at best; set realistic expectations
• Elderly patients: higher risk of fat-soluble vitamin deficiency; supplement with vitamins A, D, E, and K if using chitosan regularly
• Vegetarians/vegans: fungal-derived chitosan is available as an alternative to shellfish-derived products
• Diabetic patients: some evidence suggests chitosan may modestly affect blood glucose; monitor accordingly

Pharmacokinetic Profile